Browser-side verification
Verify Cefalexin
คุณไม่ต้องเชื่อ source.cuvetsmo.com — โค้ดด้านล่างทำงานในเครื่องของคุณ คำนวณ SHA-256 และ verify Ed25519 signature เทียบกับ public key ที่อาจารย์เซ็นต์รับเก็บไว้.
Signatures
0
Version
1
Status
pending
⏳ ยังไม่มี signature
Entry นี้ยังไม่ได้ลงนามโดย key ใดเลย — Phase 0 mirror snapshot ที่รอ Thai translation + faculty signoff. ดูสถานะการ review ที่ หน้า detail
Show the raw inputs (paranoid mode)
Drug JSON
This is exactly what your browser canonicalizes + SHA-256-hashes
{
"slug": "cefalexin",
"nameEn": "Cefalexin",
"nameTh": "เซฟาเล็กซิน",
"class": "Antibiotic — first-generation cephalosporin (β-lactam)",
"mechanism": "ยาปฏิชีวนะ β-lactam กลุ่ม cephalosporin รุ่นที่ 1 ยับยั้งการสร้างผนังเซลล์แบคทีเรีย; ออกฤทธิ์ดีต่อ gram-positive (โดยเฉพาะ Staphylococcus) แต่ครอบคลุม gram-negative ได้ปานกลางเท่านั้น",
"brandNamesTh": [
"Keflex",
"Rilexine",
"Therios"
],
"indications": [
{
"text": "ติดเชื้อผิวหนังและเนื้อเยื่ออ่อน (pyoderma), ทางเดินปัสสาวะ, กระดูก ที่เกิดจากเชื้อ gram-positive โดยเฉพาะ Staphylococcus; ออกฤทธิ์น้อยต่อ E. coli",
"cites": [
"merck-cephalosporins-and-cephamycins-use-in-animals"
]
}
],
"contraindications": [
{
"text": "ห้ามใช้ในสัตว์ที่แพ้ cephalosporin; ระวัง cross-reactivity ในสัตว์ที่แพ้ penicillin",
"cites": [
"merck-cephalosporins-and-cephamycins-use-in-animals"
]
}
],
"sideEffects": [
{
"text": "คลื่นไส้ อาเจียน ท้องเสีย; อาจเกิด antimicrobial-induced colitis และปฏิกิริยาภูมิแพ้",
"cites": [
"merck-cephalosporins-and-cephamycins-use-in-animals"
]
}
],
"dosages": [
{
"species": "canine",
"indication": "Pyoderma / soft-tissue / UTI",
"route": "PO",
"dose": "15–45 mg/kg ทุก 6–12 ชั่วโมง",
"cites": [
"merck-cephalosporins-and-cephamycins-use-in-animals"
]
},
{
"species": "feline",
"indication": "Skin / soft-tissue infection",
"route": "PO",
"dose": "15–35 mg/kg ทุก 6–12 ชั่วโมง",
"cites": [
"merck-cephalosporins-and-cephamycins-use-in-animals"
]
}
],
"citations": [
{
"id": "merck-cephalosporins-and-cephamycins-use-in-animals",
"type": "textbook",
"title": "Cephalosporins and Cephamycins — MSD/Merck Veterinary Manual (Pharmacology)",
"year": 2025,
"url": "https://www.merckvetmanual.com/pharmacology/antibacterial-agents/cephalosporins-and-cephamycins-use-in-animals",
"note": "Authoritative veterinary pharmacology reference — verified dose, spectrum, adverse-effect profile. Copyrighted, cited not mirrored.",
"cid": null
},
{
"id": "wikipedia-Cefalexin",
"type": "monograph",
"title": "Cefalexin — Wikipedia",
"year": 2026,
"url": "https://en.wikipedia.org/wiki/Cefalexin",
"note": "Tertiary cross-check for class, mechanism, brand names. CC BY-SA 4.0. Not sole authority for any clinical claim.",
"cid": null
},
{
"id": "dailymed-cefalexin",
"type": "regulatory-database",
"title": "Cefalexin — NLM DailyMed (FDA Structured Product Labeling)",
"year": 2025,
"url": "https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=cefalexin",
"note": "Cross-checked source: FDA-approved labeling. Search by name returns relevant product labelings.",
"cid": "eca25df94b2b1b8b99200e3f79113574d55f82fb35f56780ba6db3e06cf4721b"
},
{
"id": "atc-J01DB01",
"type": "guideline",
"title": "ATC J01DB01 — Cefalexin",
"year": 2025,
"url": "https://www.whocc.no/atc_ddd_index/?code=J01DB01&showdescription=no",
"note": "Cross-checked source: WHO Collaborating Centre ATC/DDD index. Authoritative drug classification.",
"cid": "bf4c7f25583d2aa7656c90770c0ca5ffe40e6d4b706bd16596ee9c8f57f689e7"
},
{
"id": "pubchem-cefalexin",
"type": "monograph",
"title": "Cefalexin — PubChem search",
"year": 2025,
"url": "https://pubchem.ncbi.nlm.nih.gov/#query=Cefalexin",
"note": "Cross-checked source: chemical structure, identifiers, pharmacology summary. Faculty review fills exact CID.",
"cid": "bdd2cfe10dba4f139683077630338f94c55719db8cb72733680c13f2d976b877"
},
{
"id": "who-eml-22",
"type": "guideline",
"title": "WHO Model List of Essential Medicines (22nd List, 2021)",
"year": 2021,
"url": "https://www.who.int/publications/i/item/WHO-MHP-HPS-EML-2021.02",
"note": "Cross-checked source: drug appears on WHO EML — WHO recognizes its place in basic healthcare.",
"cid": "71030c795c4e0c0cff56566bfc9ae4ed448eab9188ae68ce773a50d9f7fc53eb"
},
{
"id": "wsava-amr-2023",
"type": "guideline",
"title": "WSAVA Therapeutic Guidelines Group — Library on Responsible Antimicrobial Use and AMR Prevention (2023)",
"year": 2023,
"url": "https://wsava.org/wp-content/uploads/2023/05/WSAVA-TGG-library-on-responsible-antimicrobial-use-and-AMR-prevention-2.pdf",
"note": "Cross-checked source: WSAVA TGG framework for prudent antibiotic use in companion animals (PDF, stable URL).",
"cid": "29f7ea6edf16004626349e036f3eb2ea30803ca1f6efd437bff0e8a4f2f465f1"
}
],
"mirroredFrom": [
{
"id": "dailymed",
"name": "NLM DailyMed",
"url": "https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=cefalexin",
"asOfDate": "2026-05-27",
"license": "U.S. Government work — public domain. Attribution recommended."
},
{
"id": "atc",
"name": "WHO ATC Classification",
"url": "https://www.whocc.no/atc_ddd_index/?code=J01DB01&showdescription=no",
"asOfDate": "2026-05-27",
"license": "WHO publication, free for use with attribution"
},
{
"id": "pubchem",
"name": "PubChem (NIH/NLM)",
"url": "https://pubchem.ncbi.nlm.nih.gov/#query=Cefalexin",
"asOfDate": "2026-05-27",
"license": "NIH/NLM public domain"
},
{
"id": "who-eml",
"name": "WHO Model List of Essential Medicines (22nd List, 2021)",
"url": "https://www.who.int/publications/i/item/WHO-MHP-HPS-EML-2021.02",
"asOfDate": "2026-05-27",
"license": "CC BY-NC-SA 3.0 IGO"
},
{
"id": "wsava-amr",
"name": "WSAVA TGG — Key Documents on Responsible Antimicrobial Use and AMR Prevention",
"url": "https://wsava.org/wp-content/uploads/2023/05/WSAVA-TGG-library-on-responsible-antimicrobial-use-and-AMR-prevention-2.pdf",
"asOfDate": "2026-05-27",
"license": "Free for educational use with attribution"
}
],
"mirrorCIDs": [
{
"sourceId": "dailymed",
"cid": "eca25df94b2b1b8b99200e3f79113574d55f82fb35f56780ba6db3e06cf4721b",
"capturedAt": "2026-05-27",
"status": "stub"
},
{
"sourceId": "atc",
"cid": "bf4c7f25583d2aa7656c90770c0ca5ffe40e6d4b706bd16596ee9c8f57f689e7",
"capturedAt": "2026-05-27",
"status": "stub"
},
{
"sourceId": "pubchem",
"cid": "bdd2cfe10dba4f139683077630338f94c55719db8cb72733680c13f2d976b877",
"capturedAt": "2026-05-27",
"status": "stub"
},
{
"sourceId": "who-eml",
"cid": "71030c795c4e0c0cff56566bfc9ae4ed448eab9188ae68ce773a50d9f7fc53eb",
"capturedAt": "2026-05-27",
"status": "stub"
},
{
"sourceId": "wsava-amr",
"cid": "29f7ea6edf16004626349e036f3eb2ea30803ca1f6efd437bff0e8a4f2f465f1",
"capturedAt": "2026-05-27",
"status": "stub"
}
],
"codes": {
"atc": {
"code": "J01DB01",
"name": "Cefalexin",
"level": 5
},
"rxnorm": {
"cui": "2231",
"name": "Cefalexin"
}
},
"drafting": {
"aiAssisted": false,
"aiModel": null,
"aiPromptHash": null,
"humanReviewer": "palmzamak2547",
"humanReviewedAt": "2026-05-27",
"humanEditsRatio": null
},
"signatures": [],
"reviewedBy": null,
"lastUpdated": "2026-05-27",
"version": 1,
"changelog": [
{
"version": 0,
"date": "2026-05-27",
"summary": "Seed entry — cross-checked from 5 authoritative sources (NLM DailyMed, WHO ATC Classification, PubChem (NIH/NLM), WHO Model List of Essential Medicines (22nd List, 2021), WSAVA TGG — Key Documents on Responsible Antimicrobial Use and AMR Prevention). ATC J01DB01 + RxNorm 2231. Thai translation + faculty review pending."
},
{
"version": 1,
"date": "2026-05-27",
"summary": "Clinical content compiled from cited sources — cefalexin dog 15–45 / cat 15–35 mg/kg verified against Merck Veterinary Manual (Cephalosporins). Every statement cited. Reviewed by palmzamak2547. Pending faculty canonical signature."
}
]
}Public keys used
[]